Filing Details
- Accession Number:
- 0001179110-18-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-02 15:39:21
- Reporting Period:
- 2017-12-28
- Accepted Time:
- 2018-01-02 15:39:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509669 | S Philip Low | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Chief Science Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-28 | 65,445 | $3.06 | 354,050 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-12-28 | 50,511 | $4.41 | 303,539 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-22 | 8,333 | $0.00 | 184,985 | No | 5 | G | Indirect | By spouse trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 5 | G | Indirect | By spouse trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-12-28 | 65,445 | $0.00 | 65,445 | $3.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-02-12 | No | 4 | M | Direct |
Footnotes
- Represents the sale of 50,511 shares in multiple transactions, ranging in price from $4.2700 to $4.5100 per share, resulting in a weighted average sale price per share of $4.4114. These shares were sold to cover the option exercise cost, taxes and fees in connection with the reporting person's exercise of stock options on December 28, 2017 as reported herein. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
- Represents a gift of 8,333 shares by Spouse Trust to a non-profit organization.
- The option is fully vested and immediately exercisable.